Sale!

RUBCN Gene Salih Ataxia Genetic Test

Name: RUBCN Gene Salih Ataxia Genetic Test
SKU: TEST-1961
Price: 4400 AED
Availability: InStock

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The RUBCN Gene Salih Ataxia Genetic Test is a specialized diagnostic tool designed to detect mutations in the RUBCN gene, which are implicated in the development of Salih Ataxia, a rare neurodegenerative disorder. This condition is characterized by a progressive loss of coordination and movement, leading to significant physical disability over time. The test is particularly relevant for individuals exhibiting symptoms of ataxia, those with a family history of the condition, or couples considering pregnancy and wishing to assess their risk of passing the condition onto their offspring.

Conducted at DNA Labs UAE, a leading facility in genetic testing and analysis, the test involves collecting a DNA sample from the patient, typically through a blood draw or a cheek swab. The sample is then analyzed using advanced genetic sequencing technologies to identify any mutations in the RUBCN gene that are known to cause Salih Ataxia.

The cost of the RUBCN Gene Salih Ataxia Genetic Test is 4400 AED, reflecting the sophisticated technology and expert analysis involved in its execution. Despite the price, for many patients and families, the test provides invaluable insights into their genetic health, guiding treatment decisions, and offering a clearer understanding of their condition’s progression and inheritance pattern.

Description

RUBCN Gene Salih Ataxia Genetic Test

Components: RUBCN Gene Salih ataxia Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for RUBCN Gene Salih ataxia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with RUBCN Gene Salih ataxia.

Test Details: The RUBCN gene, also known as the RUBCN-like protein, is associated with ataxia, a neurological disorder characterized by lack of coordination and balance. Ataxia can be caused by various genetic mutations, and Next-Generation Sequencing (NGS) genetic testing is a tool used to identify these mutations. NGS genetic testing involves sequencing the DNA of an individual to identify any genetic variations or mutations that may be causing a specific condition or disease. In the case of ataxia, NGS can be used to analyze the RUBCN gene and identify any mutations that may be contributing to the development of the disorder. By identifying the specific genetic mutation causing ataxia, NGS testing can provide valuable information for diagnosis, prognosis, and potential treatment options. It can also help in identifying carriers of the mutation, which can be important for genetic counseling and family planning. It is important to note that genetic testing should be conducted under the guidance of a healthcare professional or genetic counselor who can interpret the results and provide appropriate recommendations based on the individual’s specific situation.

Test Name	RUBCN Gene Salih ataxia Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Neurological Disorders
Doctor	Neurologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for RUBCN Gene Salih ataxia NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with RUBCN Gene Salih ataxia
Test Details	The RUBCN gene, also known as the RUBCN-like protein, is associated with ataxia, a neurological disorder characterized by lack of coordination and balance. Ataxia can be caused by various genetic mutations, and Next-Generation Sequencing (NGS) genetic testing is a tool used to identify these mutations. NGS genetic testing involves sequencing the DNA of an individual to identify any genetic variations or mutations that may be causing a specific condition or disease. In the case of ataxia, NGS can be used to analyze the RUBCN gene and identify any mutations that may be contributing to the development of the disorder. By identifying the specific genetic mutation causing ataxia, NGS testing can provide valuable information for diagnosis, prognosis, and potential treatment options. It can also help in identifying carriers of the mutation, which can be important for genetic counseling and family planning. It is important to note that genetic testing should be conducted under the guidance of a healthcare professional or genetic counselor who can interpret the results and provide appropriate recommendations based on the individual’s specific situation.